Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

AIM: To confirm previous conclusions on Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 for irritable bowel syndrome (IBS) management. METHODS: An individual patient data meta-analysis was performed on two randomized clinical trials studying the effect of S. cerevisiae CNCM I-3856 supplementati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cayzeele-Decherf, Amélie, Pélerin, Fanny, Leuillet, Sébastien, Douillard, Benoit, Housez, Béatrice, Cazaubiel, Murielle, Jacobson, Gunnard K, Jüsten, Peter, Desreumaux, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236513/
https://www.ncbi.nlm.nih.gov/pubmed/28127207
http://dx.doi.org/10.3748/wjg.v23.i2.336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236513/
https://www.ncbi.nlm.nih.gov/pubmed/28127207
http://dx.doi.org/10.3748/wjg.v23.i2.336

Ejemplares similares